Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCXI | CRNX | PTCT | ||
| Company | Chemocentryx Inc | Crinetics Pharmaceuticals Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 51.98 | 60.13 | 42.74 | ||
| High | 52.00 | 60.15 | 42.74 | ||
| Low | 51.98 | 54.42 | 38.94 | ||
| Last | 51.99 | 54.72 | 39.23 | ||
| Change | +0.03 | -4.94 | -3.15 | ||
| % Change | +0.06% | -8.28% | -7.43% | ||
| Volume | 2,480,300 | 901,340 | 1,027,112 | ||
| 20-Day Average Volume | 1,231,860 | 642,249 | 747,174 | ||
| Previous Close | 51.96 | 59.66 | 42.38 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.83 | 58.08 | 41.67 | ||
| 20-Day Raw Stochastic | 97.78% | 4.45% | 18.22% | ||
| 20-Day Relative Strength | 79.02% | 45.78% | 48.67% | ||
| Weighted Alpha | +1.40 | +60.17 | +79.71 | ||
| Today's Opinion | 100% Buy | 64% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.08% since 10/12/22 | -9.89% since 11/08/24 | -11.13% since 11/08/24 | ||
| Low | 51.90 on 10/13/22 | 54.42 on 11/15/24 | 38.94 on 11/15/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| 1-Month | |||||
| %Chg | +0.83% since 09/19/22 | -5.06% since 10/15/24 | +4.77% since 10/15/24 | ||
| Low | 51.55 on 09/23/22 | 54.32 on 10/31/24 | 35.51 on 10/17/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +120.86% since 07/19/22 | +4.10% since 08/15/24 | +19.10% since 08/15/24 | ||
| Low | 21.87 on 07/25/22 | 49.13 on 09/24/24 | 30.41 on 09/05/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +145.24% since 04/19/22 | +8.31% since 05/15/24 | +16.90% since 05/15/24 | ||
| Low | 14.95 on 05/09/22 | 41.01 on 06/26/24 | 28.72 on 06/28/24 | ||
| High | 52.00 on 10/19/22 | 62.53 on 11/14/24 | 46.98 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 5,532,749 | 3,268,558 | ||
| Shares Outstanding, K | 71,356 | 92,738 | 77,125 | ||
| Annual Sales | 32,220,000 | 4,010,000 | 937,820,000 | ||
| Annual Net Income | -131,760,000 | -214,530,000 | -626,600,000 | ||
| Last Quarter Sales | 11,760,000 | 400,000 | 196,790,000 | ||
| Last Quarter Net Income | -31,650,000 | -74,050,000 | -106,650,000 | ||
| 60-Month Beta | 1.22 | 0.62 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.96 on 11/12/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 11/08/22 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||